Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

BACKGROUND: The gut microbiome impacts the efficacy of immune checkpoint inhibitor (ICI) therapy and the development of ICI-mediated diarrhea and/or colitis (IMDC). Antibiotic therapy,especially that with anaerobic activity, has profound effects on the gut microbiome. Therefore, we sought to assess...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Maria P., Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729015/
https://ncbi.nlm.nih.gov/pubmed/31488205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0714-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars